5th Annual Women's Cardiovascular Symposium

Friday, September 25, 2026

The Summit Hotel
5345 Medpace Way
Cincinnati, OH 45227
8 am-5 pm

Presented by The Christ Hospital Health Network Women's Heart Center & Mass General Brigham

Return to Anchor Link Navigation - Top of Page

Overview/Registration

2026 Registration is open!

With cardiovascular disease remaining the leading cause of death for women in the United States, morbidity and mortality rates continue to rise despite medical advances and public health awareness campaigns. Persistent knowledge gaps in sex-specific risk factors and differences in clinical presentation often lead to delayed care. Even when women seek medical attention, they are frequently misdiagnosed or undertreated.

To address these alarming disparities, The Women’s Heart Center at The Christ Hospital established the Women’s Cardiovascular Symposium, offering continuing medical education for physicians and healthcare professionals managing cardiovascular disease (CVD) in women. This symposium focuses on advancing sex-specific risk assessments and evidence-based strategies to improve clinical outcomes and bridge the care gap for women with or at risk of CVD. As the only educational program in the Midwest focused on sex- and gender-specific cardiovascular differences, it remains an essential resource for healthcare providers.

This year, we are proud and excited to collaborate with Mass General Brigham, further expanding the symposium’s impact and reinforcing our mission to transform women’s heart health. On behalf of The Christ Hospital and Mass General Brigham, we invite you to join us for the 5th Annual Women’s Cardiovascular Symposium, held on Friday, September 25, 2026, in beautiful Cincinnati, Ohio. We look forward to seeing you there!

*If you are a trainee (student, resident, or fellow), please email WHC@TheChristHospital.com for a special discount code. Please include your institution and trainee status and copy your director or other faculty member who can verify your trainee status.

**TCHCVA non-provider employees can email WHC@TheChristHospital.com for a special discount code.

Download Agenda Email for Inquiries

We are recognized as the #1 Hospital in Greater Cincinnati with high performance in Cardiology & Heart Surgery for heart failure, heart attack, heart bypass surgery, and aortic valve surgery. Publications such as Newsweek, Forbes/Premier, and U.S. News & World Report rank The Christ Hospital among the Best Hospitals in the U.S. for Cardiology.

Return to Anchor Link Navigation - Top of Page

2026 Faculty

Michelle Albert, MD, MPH, FACC, FAHA

Michelle Albert, MD, MPH, FACC, FAHA

Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and Professor in Medicine at the University of California at San Francisco

Admissions Dean for UCSF Medical School

Dr. Michelle A. Albert, is the Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and Professor in Medicine at the University of California at San Francisco (UCSF), Admissions Dean for UCSF Medical School and Director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center). Dr. Albert is a graduate of Haverford College, the University of Rochester School of Medicine and Harvard School of Public Health. She completed Internal Medicine Residency and served as Chief Medical Resident at Columbia University Medical Center in New York. Dr. Albert then completed Cardiovascular Clinical and Research Fellowship at the Brigham and Women’s Hospital and Harvard Medical School, where she rose in the ranks to an Associate Professor in Medicine. She was previously the Vivian Beaumont Allen Endowed Professor/Chair and Chief of Cardiology at Howard University.

Dr. Albert’s clinical expertise involves both taking care of the most critically ill heart disease patients and preventive cardiology at UCSF. As a physician-scientist-epidemiologist, Dr. Albert has had a longstanding commitment to health equity and is engaged in cutting-edge research that innovatively seeks to incorporate “biology” with social determinants of health to transform CVD science and healthcare of global populations, i.e “the biology of adversity.”

Katie Berlacher, MD, MS, FACC

Katie Berlacher, MD, MS, FACC

Clinical & Strategic Director of Cardiology, Director of Women's Heart Program

Dr. Berlacher is a cardiologist certified in cardiovascular disease by the American Board of Internal Medicine and adult echocardiography. She is the medical director of the Magee Women’s Heart Program, the Program Director of the Cardiovascular Fellowship, the Associate Chief of Education for the Heart & Vascular Institute and the Chief of Medine at Magee Women’s Hospital. She is an associate professor of medicine at the University of Pittsburgh School of Medicine. She received her medical degree from The Ohio State University and completed her residency with a focus on women's health and fellowship at the University of Pittsburgh Medical Center.

Dr. Berlacher joined the UPMC Heart and Vascular Institute in 2012. Her clinical interests include women’s heart disease, including high-risk pregnancy related to risk of or known heart disease, as well as medical education. She has published numerous articles in peer-reviewed journals and is a member of the American College of Cardiology and the American Heart Association. She lives in the city and is an avid cyclist, boxer, and hiker.

LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling.

Ron Blankstein, MD, FACC, FASNC, MSCCT, FASPC

Ron Blankstein, MD, FACC, FASNC, MSCCT, FASPC

Associate Director, Cardiovascular Imaging

Program Director, Cardiac Computed Tomography

Co-Director, Cardiovascular Imaging Training Program

Professor of Medicine, Harvard Medical School

Cardiovascular Medicine, Radiology

Dr. Ron Blankstein is the Associate Director of the Cardiovascular Imaging Program, Director of Cardiac Computed Tomography, and a preventative cardiology specialist at Brigham and Women’s Hospital (BWH). In addition, he is a Professor of Medicine at Harvard Medical School (HMS).

Dr. Blankstein is the immediate Past-President of the Society of Cardiovascular Computed Tomography and serves on the Board of Directors of the American Society of Preventive Cardiology. He received his medical degree from Rush Medical College. He completed an internal medicine residency and a cardiology fellowship at the University of Chicago Medical Center. Dr. Blankstein then completed an advanced fellowship in cardiac imaging at Massachusetts General Hospital. He is certified in cardiovascular disease, nuclear cardiology, and cardiovascular computed tomography.

His clinical interests focus on methods to identify and treat early stages of coronary heart disease, prevention of cardiovascular disease, and diagnosis and treatment of cardiac sarcoidosis. Dr. Blankstein is an expert in the use of multi-modality imaging for the assessment of cardiovascular disease. This includes acquiring and interpreting non-invasive cardiovascular imaging tests—such as cardiac MRI, cardiac CT, nuclear cardiology, and exercise treadmill testing. The author of over 400 publications, Dr. Blankstein’s research compares the results of different imaging techniques as well as the impact of these tests on the patient management and outcomes. Dr. Blankstein frequently lectures on topics ranging from preventive cardiology and risk assessment to how to use the results of cardiovascular imaging in patient management decisions.

Laura Cohen, MD, MPP

Laura Cohen, MD, MPP

Dr. Laura Cohen is a board-certified cardiologist with specialized expertise in cardiovascular disease and comprehensive echocardiography. She completed fellowships in Cardiovascular Disease (2021) and Echocardiography (2022) at Columbia University Medical Center after finishing her Internal Medicine residency there in 2017. Dr. Cohen earned her medical degree from Harvard Medical School in 2014.

Dr. Cohen is board certified in Internal Medicine by the American Board of Internal Medicine and in Adult Comprehensive Echocardiography by the National Board of Echocardiography. Her clinical interests include advanced cardiac imaging and the diagnosis and management of cardiovascular disease, with a commitment to providing evidence-based, patient-centered care.

Colleen Harrington, MD, FACC, FASE

Colleen Harrington, MD, FACC, FASE

Assistant Professor of Medicine

Associate Program Director of the MGH cardiovascular fellowship program

Cardiologist for Women’s Heart Health Program and Cardio-Obstetrics Program at Massachusetts General Hospital

Dr. Colleen Harrington earned her medical degree from Drexel University College of Medicine and was inducted into the Alpha Omega Alpha Honor Society. She was the recipient of The Janet M. Glasgow Memorial Achievement Citation of the American Medical Women’s Association for academic excellence, The Beatrice Sterling Hollander, MD Award for leadership, high character and creativeness in the medical profession and the William Likoff, MD Award for distinction in the care of medical patients and academic excellence

She completed her clinical training in Internal Medicine at Johns Hopkins Hospital and received the Normal D. Anderson Award by the Osler Internal Medicine Residency for outstanding, compassionate care in the ambulatory setting. She served as chief resident (Assistant Chief of Service) of the Osler Medicine House Staff Program and Instructor of Medicine of the Johns Hopkins University School of Medicine. She then completed her cardiovascular fellowship at Johns Hopkins Hospital which included an advanced fellowship in echocardiography and coronary CT angiography.

Prior to joining Massachusetts General Hospital, Dr. Harrington was an Assistant Professor of Medicine at Johns Hopkins University School of Medicine and then at the University of Massachusetts Chan Medical School where she was awarded the Early Career Achievement Award in Medicine and Research in 2020. She also served as the Associate Program Director of the cardiovascular fellowship program and Co-Director of the cardiovascular disease and pregnancy clinic.

Dr. Harrington is a faculty member of the Women’s Heart Health Program and Cardio-Obstetrics Program at Massachusetts General Hospital. She is an Associate Program Director of the MGH cardiovascular fellowship program. Her clinical and research interests include cardiovascular disease in women, cardio-obstetrics, preventive cardiology, and noninvasive cardiovascular imaging. She is board certified in Internal Medicine, Cardiovascular Medicine, Echocardiography and Coronary CT angiography. She is the current Governor of the Massachusetts Chapter of the American College of Cardiology.

Sarah Bartlett, MD, FACOG

Sarah Bartlett, MD, FACOG

Obstetrician-Gynecologist
Am Bd of Ob & Gyn (Obstetrics & Gynecology)

Sarah Bartlett, MD is a board-certified physician with The Christ Hospital Physicians who specializes in gynecology with a special interest in comprehensive women’s wellness and preventative care.

She treats patients at the Norwood and Liberty Township locations and performs a full range of gynecologic services including all forms of contraception and hormone therapy. She is certified as a menopause practitioner.

Dr. Bartlett earned a Bachelor of Arts in Psychology with a minor in Biology from St. Louis University, graduating magna cum laude from the honors program. She earned her Medical Degree from the University of Louisville School of Medicine and completed an internship in internal medicine and a residency in obstetrics & gynecology at the University of Cincinnati Medical Center.

She is certified by the American Board of Obstetrics & Gynecology, and she is a member of the American College of Obstetricians and Gynecologists and The Menopause Society.

In her free time, Dr. Bartlett enjoys travel, baking, and fitness.

Anju Nohria, MD, MSc

Anju Nohria, MD, MSc

Clinical Professor of Medicine, Department of Medicine at NYU Grossman School of Medicine

Director, Cardio-Oncology Program, NYU Langone Hospitals - Manhattan

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Assistant Professor of Medicine at Harvard Medical School (HMS).
Dr. Nohria received her medical degree from HMS. She completed an internal medicine residency and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at BWH. She is board certified in cardiovascular disease and heart failure and transplantation.
Dr. Nohria’s clinical interests include cardio-oncology and heart failure and transplantation. The author of over 60 peer-reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications that can arise as a consequence of cancer therapy.

Maria Pabon Porras, MD

Maria Pabon Porras, MD

Cardiologist at Brigham and Women's Hospital, Instructor of Medicine at Harvard Medical School

Dr. Pabon Porras, originally from Cucuta, Colombia, is a cardiologist at Brigham and Women’s Hospital, a teaching hospital of Harvard Medical School. She completed her medical degree at the Universidad Nacional de Colombia and subsequently trained in internal medicine at NewYork-Presbyterian/Weill Cornell Medical Center, before coming to Brigham and Women’s Hospital for her clinical and research fellowship in cardiovascular medicine, which she completed in 2024. She is board-certified in cardiology and internal medicine.

Dr. Pabon is a general cardiologist who cares for a broad range of cardiovascular patients, with particular clinical and research expertise in cardiovascular women’s health and cardio-obstetrics. Her work aims to address critical gaps in the understanding of sex-specific differences in cardiovascular disease. Her research spans basic, translational, and clinical investigation, with a focus on uncovering sex-specific mechanisms of disease, defining the relationship between adverse reproductive outcomes and future cardiovascular risk, particularly heart failure, and translating these insights into clinical trials that improve prevention and treatment strategies for women. She also serves as Associate Director of the Cardiovascular Imaging Core Laboratory at Brigham and Women’s Hospital.

Rita Redberg, MD, MS, FACC, FAHA

Rita Redberg, MD, MS, FACC, FAHA

Professor of Medicine, Araxe Vilensky Endowed Chair in Cardiology

Core Faculty, Philip R Lee Institute for Health Policy Studies

Director, Inquiry Program, UCSF Division of Cardiology

Dr. Rita Redberg is a cardiologist who practices general and preventive cardiology. She is passionate about helping her patients adopt healthful lifestyle behaviors to reduce their heart disease risk and stay healthy. She also has an interest in promoting high-value health care, an approach that emphasizes delivering appropriate treatments while avoiding tests or therapies with no known benefits.

In her research, Redberg looks at how the assessment of medical technology's safety and effectiveness influences – and is influenced by – public health policy. In particular, she studies high-risk medical devices and women's inclusion in clinical trials for such devices.

As editor of JAMA Internal Medicine, a journal of the American Medical Association, from 2009 to 2023, she spearheaded the publication's new focus on health care reform and less-is-more medicine, a movement to reduce unnecessary interventions.

Redberg earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She completed a residency in internal medicine and a fellowship in cardiology at Columbia University Medical Center. She completed a fellowship in noninvasive cardiology at the Mount Sinai Health System. She also has a master's degree in health policy and administration from the London School of Economics and Political Science.

Jackie Saw, MD, FRCPC, FACC, FSCAI, FAHA, FSCCT

Jackie Saw, MD, FRCPC, FACC, FSCAI, FAHA, FSCCT

Clinical Professor, University of British Columbia | Interventional Cardiology, Vancouver General Hospital

Dr. Jacqueline Saw is a clinical professor at University of British Columbia (UBC) and program director of the Interventional Cardiology Fellowship Program at Vancouver General Hospital (VGH) She is an interventional cardiologist at VGH, with joint appointment at St Paul’s Hospital.

Dr. Saw was awarded Canada Scholar and the Dean’s Entrance Scholarship for Natural Sciences at Simon Fraser University, where she did her undergraduate degree. She then obtained her medical doctorate at the University of Ottawa, where she graduated summa cum laude. She did her residency training in internal medicine and cardiology at the UBC and served as Chief Cardiology Fellow. She then proceeded to interventional cardiology fellowship training at the Cleveland Clinic, which encompassed carotid, peripheral and structural interventional training. She has been an active staff with the Division of Cardiology at VGH and joint appointment at St Paul’s Hospital since 2004. She is also a physician proctor/preceptor for left atrial appendage (LAA) closure with the Amplatzer Cardiac Plug/Amulet and WATCHMAN devices.

Dr. Saw’s research interests include spontaneous coronary artery dissection (SCAD), antiplatelet therapy, percutaneous coronary intervention, carotid artery stenting, peripheral intervention, LAA closure and non-atherosclerotic coronary artery. She is the principal investigator of the Canadian SCAD Study, PRYME, NACAD, SAFER-SCAD, Canadian WATCHMAN Registry, TAP-CABG, ELAPSE, and ASAP-TOO studies. She has authored or co-authored over 300 publications, including scientific research studies, review articles and book chapters. She is also the editor of two textbooks on carotid artery stenting and a textbook on LAA closure.

Nandita Scott, MD, FACC, FASE

Nandita Scott, MD, FACC, FASE

Ellertson Family Endowed Chair in Cardiovascular Medicine
Director, Mass General Brigham Women's Heart Health Program
Director, Cardiovascular Medicine Section, Massachusetts General Hospital

Dr. Scott earned her MD from the University of Ottawa in Canada, where she also completed her Internal Medicine and Cardiology Residencies, serving as Chief Resident in both programs. She completed an echocardiography and clinical research fellowship at Massachusetts General Hospital (MGH) from 2000 to 2002. In 2007, she co-founded the MGH Corrigan Women’s Heart Health Program, which has since evolved into a robust clinical, educational, and research hub. She also established the MGH Cardiovascular Disease and Pregnancy Program, forging a formal collaboration between cardiology, maternal-fetal medicine, and obstetric anesthesia—fundamentally transforming and enhancing patient care in this area.

Dr. Scott is the inaugural director of the integrated Mass General Brigham Women’s Heart Health Program and was a founding investigator for the HOPE pilot study in collaboration with St. Luke’s in Kansas City, MO, which aims to characterize outcomes in a cohort of women with heart disease during pregnancy. She serves on the steering committee for the NHLBI-funded study, encompassing 36 sites across the country.

A recognized leader in the care of patients with spontaneous coronary artery dissection (SCAD), Dr. Scott was invited to join the steering committee of the iSCAD international collaboration of expert centers. Her work has earned several accolades, including the 2020 Women’s Heart Research Award from the Massachusetts Medical Society. Recently, she was selected as part of the first cohort of the Mass General Brigham Healthcare Leadership Program and also serves as the Director of Cardiovascular Medicine at Massachusetts General Hospital.

Pam Taub, MD, FACC, FASPC

Pam Taub, MD, FACC, FASPC

Professor of Medicine. Step Family Director's Endowed Chair, Director of Preventive Cardiology

Dr. Pam Taub is a board-certified cardiologist specializing in general and preventive cardiology. She is an internationally recognized researcher and expert in cardiometabolic disease.

Dr. Taub believes that prevention is the new frontier in cardiovascular medicine. She takes an evidence-based approach to care and tailors it to each patient, with the goal of minimizing medications and procedures. She also collaborates closely with other specialists to provide cardiac care for patients with complex, multi-system diseases such as cancer and autoimmune disease.

She is the director of Preventive Cardiology, the founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center, and a professor of medicine with tenure at UC San Diego. She also holds the Step Family Director's Endowed Chair. Dr. Taub was responsible for all aspects of creating the center, which is one of the largest comprehensive cardiac rehabilitation programs in the world. She also leads the newly formed BEACON Center for Lipoprotein (a) Research and Innovation at UC San Diego.

She is active in clinical and translational research with continuous funding from the National Institutes of Health for the past 15 years, and serves as the principal investigator on multiple R01 grants. She has also received research funding from the Department of Defense, Department of Homeland Security, and American Heart Association. She is an experienced clinical trialist and serves on the executive committee for multiple international clinical trials focused on novel cardiovascular therapies.

Currently, she is investigating the impact of daily fasting on improving cardiometabolic parameters and on mitochondrial function; biomarkers for cardiovascular risk factor stratification; wearable/mobile devices in improving cardiovascular outcomes; and epicatechin (a compound in dark chocolate) on mitochondrial function/cellular bioenergetics and exercise capacity.

Dr. Taub holds multiple patents, has edited several textbooks, and is widely published with more than 150 high-impact articles in leading peer-reviewed journals that have influenced clinical practice. She has also served on multiple guideline committees.

She has consistently been selected by her peers as a top physician in San Diego Magazine's "Physicians of Exceptional Excellence" annual survey performed in collaboration with the San Diego County Medical Society.
Dr. Taub completed a fellowship in cardiology at UC San Diego School of Medicine. She completed a residency in internal medicine at the University of Washington Medical Center in Seattle and earned her medical degree from Boston University School of Medicine.

Dr. Taub holds multiple leadership positions in professional societies. She is a fellow and a former board member of the American Society of Preventive Cardiology, a fellow and prior member of the American College of Cardiology's Prevention of Cardiovascular Disease Leadership Council. Currently, she serves as Chair of the American Heart Association's Women in Cardiology Committee.

Olga Toleva, MD, MPH, CCFP, FRCP

Olga Toleva, MD, MPH, CCFP, FRCP

Interventional Cardiologist, Lead Coronary Physiology Program

Dr. Olga Toleva is an interventional cardiologist with Georgia Heart Institute. Having practiced medicine for more than 20 years, Dr. Toleva also is renowned for her extensive experience in teaching, research and community outreach. She was an Associate Professor at the Emory University School of Medicine and worked in interventional cardiology at Emory St. Joseph's Hospital and at the Emory University Women's Heart Health Clinic. She previously was an assistant professor of cardiology at the University of Manitoba in Winnipeg, Canada, and an interventional cardiologist at St. Boniface Hospital in Winnipeg.

Dr. Toleva earned her medical degree from the Medical Academy in Sofia, Bulgaria, and her master's in public health from the Clinical Effectiveness Program at the Harvard T.H. Chang School of Public Health. She completed residencies in family medicine and internal medicine at the University of British Columbia, a cardiology residency at the University of Alberta, and a fellowship in interventional cardiology from the University of Alberta. Dr. Toleva joins Georgia Heart Institute as lead interventionalist for coronary physiology.

Return to Anchor Link Navigation - Top of Page

CME Information

Learning Objectives

After attending this event, attendees will be able to:

Apply best practices to elevate and manage cardiovascular diseases more prominent in women.
Articulate the need for a multidisciplinary approach in the cardiovascular management of women.
Recognize the importance of social determinants of health in the overall care of a patient.
Assess medical and/or surgical treatment options for patients with heart failure.
Accurately evaluate women presenting with chest pain.
Evaluate challenges women face regarding management of weight, lipids, diabetes, and menopause.

Accreditation

The Christ Hospital Health Network is accredited by the Ohio State Medical Association (OSMA) to provide continuing medical education to physicians.

The Christ Hospital Health Network designates this symposium for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Attendees should claim only the credit commensurate with the extent of their participation in the activity.

To earn continuing education credit, attendees must complete the following:

Sign in at the registration desk upon arrival.
Complete a course evaluation by October 16, 2026.The evaluation can be completed electronically by scanning the QR code. Paper course evaluations will also be available through the on-site CME Coordinator.
CME certificates will be emailed within a week upon verification of course evaluation completion. For those who prefer a physical copy, on-site certificates will be available upon request after evaluation completion—please see the on-site CME coordinator.

*Please ensure that when claiming continuing education credit, you provide your name and email on the evaluation form along with the number of credits you are claiming.

Return to Anchor Link Navigation - Top of Page

Abstracts

2026 Poster Session

#1 – Riester H, Gao A, Arafat S, Nicolau A, El-Hangouche N, Bae R, Seshiah P, Guddeti R, Garcia S.

Sex-Specific Association of Transmitral Gradient with Changes in Quality of Life Following Mitral Transcatheter Edge-to-Edge Repair

#10 – Nazir A, Naqvi I, Fischer K, Valencia D.

Racial disparities in Mortality among women involving Acute Myocardial Infraction and involving Heart Failure in United States: A nationwide study.

#2 – Varma B, Small A, Penfield C, Halpern D, Massera D.

A Case of Hypertrophic Cardiomyopathy with Severe Left Ventricular Outflow Obstruction: Choosing Mode of Delivery.

#11 – Nazir A, Naqvi I, Fischer K, Valencia D.

Global burden and temporal trend of cardiovascular disease attributable to high Body Mass Index, High IDL Burden, and high fasting plasma glucose: A Global Burden of Disease study

#3 – Gibbons S, Sullivan E, Cremer P, Al-Kazaz M, Luis S, Raisinghani A, Weber B, Parameswaran V, Klein A, Paolini J.

Sex Differences in the Management of Recurrent Pericarditis: Insights from the RESONANCE Registry.

#12 – Nazir A, Naqvi I, Fischer K, Valencia D.

Sex-Based Differences in Clinical Outcomes Following Transcatheter Tricuspid Edge-to-Edge Repair: A Systematic Review and Meta-analysis.

#4 – Avanigadda H, Carnesi J, Azevedo A, Ashokprabhu N, Tapp D, Hamstra M, Forrest P, Arafat S, Quesada O, Henry T.

Differences in Clinical Characteristics and Anginal Symptoms Among Patients with ANOCA Referred to Different Diagnostic Modalities.

#13 – Gibbs L, Gefert L, Chang J, Kasparian N, Arnold R, Harris K.

Fetal Cardiologists Identify Communication Priorities for Prenatal Cardiac Diagnosis.

#5 – Ashokprabhu J, Ehlers L, Masineni S, Tapp D, Azevedo A, Ashokprabhu N, Carnesi J, Forrest P, Cravero E, Hamstra M, Quesada Q, Henry T.

Clinical Characteristics, Coronary Microvascular and Vasmotor Dysfunction (CMVD) Endotypes, Echographic Findings, and H2FPEF Risk Scores in Patients with Angina with no Obstructive Coronary Arteries ANOCA), CMVD, and Elevated Left Ventricular End Diastolic Pressure (LVEDP).

#14 – Tickoo I, Aparna P, Malempati S, Thirupathy U, Susan G.

Public Interest in Heart Attack Symptoms in Women: A Google Trends Analysist (2010-2025).

#6 – Reddy S, Linkugel E, Joshi S Hanycz C, Tapp D, Azevedo A, Ashokprabhu N, Carnesi J, Forrest P, Arafat S, Hamstra M, Henry T, Quesada O.

Relationship Between Lipoprotein(a) and CMVD Endotypes in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)

#15 – Bakare S, Olaiya V, Hammed S, Moosa M.

Sex Differences pathophysiology and treatment response in HFpEF: a systematic review of differential outcomes and guideline gaps.

#7 – Pompa A, La S, McCall C, Brown S, Tavella R, Beltrame J.

Your Heart Speaks Survey Programme-the diagnostic journey of women with ANOCA.

#16 – Fischer K, Nazir Z, Reddy A, Mitiek Y, Valencia D.

Diagnostic Yield of Comprehensive Invasive Coronary Function Testing in a Newly Established ANOCA Program at Kettering Health.

#8 Pinnamaneni M, Krishnakumar M.

Silent Onset and Discordant Recovery: A Case of Pembrolizumab-Associated Myocarditis.

#17 – Oney N. Aktaruzzaman M, Lamothe C, Das M, Everett T.

Attenuated Autonomic Remodeling in Females Following Catheter Ablation for Atrial Fibrillation.

#9 Nazir A, Naqvi I, Fischer K, Valencia D.

Temporal Trends and Demographic Disparities in Mortality among Women due to Complications of Cardiac and Vascular Prosthetic Devices, Implants, and Grafts in the United States: A Nationwide Study

#18 Callender K, Brigga L, Scantlebry D.

Caught in the Octopus Pot: Estrogen, Menopause, and Takotsubo Cardiomyopathy, a Caribbean Perspective.

#19 Patel V, Rivera O, Carvalhal I, Shah K, Mittal J, Roman C, Roland M, Nunes A, Neto L, Alkan B, Modi K.

Sodium-Glucose Cotransporter 2 Inhibitors in Prevention and Treatment of Anthracycline-Related Cardiotoxicity in Adult Cancer Patients: A Systematic Review and Meta-Analysis

Return to Anchor Link Navigation - Top of Page

Hotel Information

A room block at the Summit Hotel has been generated for our guests' convenience. To reserve a room, call (866) 898-3567. The room block is listed under the 'Women's Cardiovascular Symposium hosted by The Women's Heart Center at The Christ Hospital'.

Please utilize the link below!

Online Hotel Registration Call 866-898-3567

5th Annual Women's Cardiovascular Symposium

Overview/Registration

2026 Registration is open!

2026 Faculty

Sponsors

CME Information

Abstracts

Hotel Information

Get in Touch!

Overview/Registration

2026 Registration is open!